Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for topical medications
3.2.1.2 Growing adoption of outsourcing of manufacturing activities
3.2.2 Industry pitfalls & challenges
3.2.2.1 Challenges in quality control
3.2.2.2 High capital investment
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Semi-solid formulations
5.2.1 Creams
5.2.2 Ointments
5.2.3 Gels
5.2.4 Other semi-solid formulations
5.3 Liquid formulation
5.4 Transdermal products
5.5 Solid formulations
Chapter 6 Market Estimates and Forecast, By Therapeutic Area, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Dermatology
6.3 Pain management
6.4 Wound care
6.5 Ophthalmology
6.6 Other therapeutic areas
Chapter 7 Market Estimates and Forecast, By Service Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Contract manufacturing
7.3 Contract development
Chapter 8 Market Estimates and Forecast, By End-User, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Pharmaceutical companies
8.3 Biotechnology companies
8.4 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Ascendia Pharmaceuticals
10.2 Bora Pharmaceutical CDMO
10.3 Cambrex Corporation
10.4 Contract Pharmaceuticals Limited
10.5 DPT Laboratories, Ltd.
10.6 The Lubrizol Corporation
10.7 MedPharm Ltd
10.8 PCI Pharma Services
10.9 Pierre Fabre Group
10.10 Piramal Pharma Solutions
